Kumamoto, Japan

Toshimitsu Konno


Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 87(Granted Patents)


Company Filing History:


Years Active: 1986-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Toshimitsu Konno: Innovator in Pharmaceutical Composition

Introduction

Toshimitsu Konno, an esteemed inventor located in Kumamoto, Japan, has made significant contributions to the field of pharmaceuticals. With three patents to his name, his work focuses on innovative compositions that enhance the efficacy of therapeutic agents.

Latest Patents

Among his latest patented innovations is a lyophilized pharmaceutical composition of a neocarzinostatin derivative. This composition is characterized by a specific formula that includes a stabilizing agent comprising various saccharides, aimed at preserving the integrity of the neocarzinostatin derivative during storage. Another notable patent pertains to an oily composition of aclarubicin or its hydrochloride form, which integrates fatty acids and oils to optimize its therapeutic application.

Career Highlights

Toshimitsu Konno is currently affiliated with Yamanouchi Pharmaceutical Company Ltd., where he applies his expertise in developing cutting-edge pharmaceutical formulations. His innovative approach has not only yielded patents but also advanced the effectiveness of several important treatments in the pharmaceutical industry.

Collaborations

Throughout his career, Konno has collaborated with prominent coworkers such as Hiroshi Maeda and Hiroitsu Kawata. Their combined expertise fosters an environment of creativity and innovation, driving forward the development of new pharmaceutical products.

Conclusion

Toshimitsu Konno’s journey as an inventor exemplifies the vital role of innovation in the pharmaceutical sector. His contributions through patented inventions demonstrate a commitment to improving healthcare outcomes and underscore the importance of collaborative efforts in research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…